期刊
NEUROBIOLOGY OF AGING
卷 27, 期 12, 页码 1733-1739出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2005.09.043
关键词
amyloid beta peptide; complement; Alzheimer's disease; blood; clearance
资金
- NIA NIH HHS [P30 AG19610] Funding Source: Medline
- PHS HHS [AGO7367] Funding Source: Medline
Brain deposits of amyloid (3 peptide (A(3) have been a diagnostic hallmark of Alzheimer's disease (AD) for nearly a century. Recent studies have demonstrated that A(3 is also present in peripheral blood. Here, we present evidence that circulating A(342 is subject to complement Cab-dependent adherence to complement receptor 1 (CR1) on erythrocytes, a classical set of mechanisms by which pathogens and proteins recognized as foreign are cleared from the bloodstream. Levels of A(342 targeted by this pathway differ significantly in AD compared to mild cognitive impairment and nondemented elderly controls. (c) 2005 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据